Skip to main content

2022 IF News

New Content Item (2)Clinical Hypertension 2022 Impact Factor : 4.2

You can find more details about journal's 2022 Impact Factor here.

What's new

Check out new article collections in Clinical Hypertension.

Featured research

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study

© stevepb on Pixabay

Although antihypertensive drug therapy is commonly believed to be a life-long therapy, several recent guidelines have suggested that antihypertensive medications can be gradually reduced or discontinued for some patients whose blood pressure (BP) is well-controlled for an extended period. Thus, this pilot study aimed to describe the success rate of antihypertensive drug discontinuation over 6 months among young and middle-aged patients with hypertension.

Hae-Young Lee & Kyoung Suk Lee

Clinical Hypertension volume 29, Article number: 1 (2023) 

Featured research

Prediction of cardiovascular events by central blood pressure using radial tonometry in type 2 diabetes mellitus patients

The study show the importance of CBP measurements in T2DM patients and present a cutoff value for ASCVD events and hypertension-induced complications.

Min-Sik Kim, Seon-Ah Cha & Gee-Hee Kim
Clinical Hypertension volume 28, Article number: 31 (2022) 


Archival content

Clinical Hypertension is a continuation of the Journal of the Korean Society of Hypertension, formerly published by IB Planning Co. All previous content(1995-2014) from the Journal of the Korean Society of Hypertension is freely available at  its official website.

Welcome to Clinical Hypertension

Affiliated with the Korean Society of Hypertension, Clinical Hypertension publishes in all areas of hypertension, pulmonary hypertension and vascular disorders including vascular biology, pharmacology, pediatric hypertension and imaging. Articles published in Clinical Hypertension also encompass other disciplines such as neuroscience, endocrinology, nephrology, rheumatology and nursing. Our expert Editorial Board welcomes submissions from across our subject area, and we pride ourselves on providing a swift editorial response.

Society affiliation and support of APC

Clinical Hypertension is the official journal of Korean Society of Hypertension (KSH).
KSH sponsors full amount of APC for all the articles accepted for publication so that the authors do not need to pay. 

Legacy Contents

All previous contents (1995-2014) from the Journal of the Korean Society of Hypertension are freely available at its official website.


Wook-Bum Pyun

Prof. PYUN is Professor of Medicine at Ewha Womans University, School of Medicine, Seoul Hospital, Seoul, Korea. He gained his MD degree at Yonsei University College of Medicine in Seoul, Korea and was awarded a PhD in medical science by Yonsei University. He had been served as deputy editor of Korean Circulation Journal, the official journal of Korean Society of Cardiology for more than 10 years and is immediate past president of Korean Society of Hypertension. His research interests primarily focus on blood pressure monitoring, cuff-less blood pressure measurement and renal denervation in difficult to control blood pressure

See the list of Editorial Board members.

2018 Korean Society of Hypertension guidelines for the management of hypertension

New Content ItemIn response to the growing need for revision of the hypertension treatment guideline, the Guideline Committee of the Korean Society of Hypertension have written their updated guidelines for the management of hypertension. The articles cover epidemiology, diagnosis and treatment and treatment of hypertension, and hypertension in special situations.

Indexing Services

We are pleased to announce that all articles published in Clinical Hypertension journal are covered and indexed in PubMed, PubMed Central, Web of Science (ESCI),  Scopus, EMBASE, Google Scholar, Proquest, KoreaMed, CAS and DOAJ.

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.756 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2022 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    168 days submission to accept (Median)

    2022 Usage 
    301 Altmetric mentions